Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

6.38
Delayed Data
As of Apr 17
 -0.14 / -2.15%
Today’s Change
3.10
Today|||52-Week Range
7.84
-15.61%
Year-to-Date
No recent news for Progenics Pharmaceuticals Inc.

Today’s Trading

Previous close6.52
Today’s open6.46
Day’s range6.21 - 6.50
Volume531,895
Average volume (3 months)831,466
Market cap$444.3M
Dividend yield--
Data as of 4:00pm ET, 04/17/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-983.33%
Earnings growth (next 5 years)+7.00%
Revenue growth (last year)+464.45%
P/E ratio98.7
Price/Sales11.62
Price/Book3.56

Competitors

 Today’s
change
Today’s
% change
SCLNSciClone Pharmaceuti...+0.05+0.57%
MRTXMirati Therapeutics ...-0.21-0.76%
XNPTXenoport Inc-0.25-3.38%
XOMAXOMA Corp-0.13-3.39%
Data as of 4:00pm ET, 04/17/2015

Financials

Next reporting dateMay 8, 2015
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$44.4M
Annual profit (last year)$4.4M
Net profit margin9.94%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark Robert Baker
Chief Financial Officer, Treasurer, CAO &
VP
Angelo William Lovallo
Corporate headquarters
Tarrytown, New York

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers